MichaelAlanSavinMD

PubMed

• 1 citations
  Mechanical Thrombectomy in Pulmonary Embolism Associated with COVID-19: A "Clotography" Gallery.
  Dinu V. Balanescu, Herman S. Kado, Amy Mertens, Rajat Chand, Michael Savin, Vicki McNally, Terry R. Bowers> ;Vascular and Endovascular Surgery. 2021 Aug 6
• 2 citations
  Ado-trastuzumab for the treatment of metastatic HER2-positive breast cancer in patients previously treated with Pertuzumab.
  Luai Al Rabadi, Madeline Cook, Andy Kaempf, Megan M. Saraceni, Michael A. Savin, Zahi Mitri> ;BMC Cancer. 2021 Apr 6
• 26 citations
  Everolimus Plus Exemestane Treatment in Patients with Metastatic Hormone Receptor-Positive Breast Cancer Previously Treated with CDK4/6 Inhibitor Therapy.
  Madeline Cook, Luai Al Rabadi, Andy Kaempf, Megan M. Saraceni, Michael A. Savin, Zahi Mitri> ;The Oncologist. 2021 Feb 1
• 34 citations
  Patient-reported and objectively measured physical function in older breast cancer survivors and cancer-free controls.
  Kerri M. Winters-Stone, Mary E. Medysky, Michael A. Savin> ;Journal of Geriatric Oncology. 2019 Mar 1
• 18 citations
  Patterns of Biomarker Testing Rates and Appropriate Use of Targeted Therapy in the First-Line, Metastatic Non-Small Cell Lung Cancer Treatment Setting
  Casey Mason, Peter G. Ellis, Kathy Lokay, Amanda Barry, Natalie R. Dickson, Ray D. Page, Blase N. Polite, Ravi Salgia, Michael A. Savin, Corey Shamah, Mark A. Socinski> ;Journal of Clinical Pathways. 2018 Jan 1
• Updated Survival Outcomes and Analysis of Long-Term Survivors from the MORE Study on Safety and Efficacy of Radioembolization in Patients with Unresectable Colorectal ...
  Eduardo Ehrenwald, Steven C. Rose, Michael A. Savin> ;Annals of Palliative Medicine. 2017 Sep 12
• 19 citations
  Hepatopulmonary Shunting: A Prognostic Indicator of Survival in Patients with Metastatic Colorectal Adenocarcinoma Treated with 90Y Radioembolization
  Kazim H. Narsinh, Mark Van Buskirk, Andrew S. Kennedy, Mohammed S. A. Suhail, Naif Alsaikhan, Carl K. Hoh, Kenneth G. Thurston, Jeet Minocha, David Ball, Steven J. Coh...> ;Radiology. 2017 Jan 1
• 13 citations
  Safety and Efficacy of Radioembolization in Elderly (≥ 70 Years) and Younger Patients With Unresectable Liver-Dominant Colorectal Cancer
  Andrew S. Kennedy, David Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, Samir Kanani, Steven C. Rose, Charles W. Nutting, Fr...> ;Clinical Colorectal Cancer. 2016 Jun 1
• 4 citations
  Yttrium-90 Infusion: Incidence and Outcome of Delivery System Occlusions during 885 Deliveries
  Michael Savin, Monzer Chehab, Janice Campbell, Jeffrey H. Savin, Charles Cash, Ching-yee O. Wong, Cheryl C. Schultz> ;Journal of Vascular and Interventional Radiology. 2015 Dec 1
• 12 citations
  Hepatic imaging response to radioembolization with yttrium-90-labeled resin microspheres for tumor progression during systemic chemotherapy in patients with colorectal...
  Andrew S. Kennedy, David Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, Samir Kanani, Charles W. Nutting, Fred M. Moeslein, ...> ;Journal of Gastrointestinal Oncology. 2015 Aug 24
• 27 citations
  Quantitative measurement of HER2 expression in breast cancers: comparison with 'real-world' routine HER2 testing in a multicenter Collaborative Biomarker Study and cor...
  Denise A. Yardley, Peter A. Kaufman, Weidong Huang, Lea Krekow, Michael Savin, William E Lawler, Stephen Zrada, Alexander Starr, Harvey Einhorn, Lee S. Schwartzberg, J...> ;Breast Cancer Research. 2015 Mar 18
• 60 citations
  Multicenter evaluation of the safety and efficacy of radioembolization in patients with unresectable colorectal liver metastases selected as candidates for 90 Y resin ...
  Andrew S. Kennedy, David Ball, Steven J. Cohen, Michael Cohn, Douglas M. Coldwell, Alain Drooz, Eduardo Ehrenwald, Samir Kanani, Steven C. Rose, Charles W. Nutting, Fr...> ;Journal of Gastrointestinal Oncology. 2015 Jan 15
• 13 citations
  Yttrium-90 radioembolization of malignant tumors of the liver: gallbladder effects.
  Alan A. Sag, Michael Savin, Nirish R. Lal, Rajul R. Mehta> ;AJR. American Journal of Roentgenology. 2014 Apr 23
• 7 citations
  The role of saline flush injection rate in displacement of CT-injectable peripherally inserted central catheter tip during power injection of contrast material.
  Peter Morden, Farnoosh Sokhandon, Laura S. Miller, Michael Savin, Matthias J. Kirsch, Michael Farah, Richard Silbergleit> ;AJR. American Journal of Roentgenology. 2014 Jan 1
• 23 citations
  A phase II study of eribulin mesylate (E7389) in patients with advanced, previously treated non-small-cell lung cancer.
  Alexander I. Spira, Nicholas Iannotti, Michael Savin, Marcus A. Neubauer, Nashat Y. Gabrail, Ronald H. Yanagihara, Edith A. Zang, Patricia E. Cole, Dale E. Shuster, As...> ;Clinical Lung Cancer. 2012 Jan 1
• 5 citations
  Fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography predicts extrahepatic metastatic potential of colorectal metastasis: a practical guide for yt...
  Ching Yee Oliver Wong, Vanessa L. Gates, Bingfeng Tang, Janice Campbell, Feng Qing, Robert J. Lewandowski, Joseph A. Thie, Chi Lai Ho, Michael Savin, Riad Salem> ;Cancer Biotherapy & Radiopharmaceuticals. 2010 Apr 27
• 40 citations
  Radiation microsphere–induced GI ulcers after selective internal radiation therapy for hepatic tumors: an underrecognized clinical entity
  Amulya Konda, Michael Savin, Mitchell S. Cappell, Michael C. Duffy> ;Gastrointestinal Endoscopy. 2009 Sep 1
• 6 citations
  Y-90 microsphere therapy: prevention of adverse events.
  Cheryl Schultz, Janice Campbell, Donovan Bakalyar, Michele Beauvais, W Feng, Michael Savin> ;Cancer Biotherapy & Radiopharmaceuticals. 2009 Aug 20
• 169 citations
  Treatment Parameters and Outcome in 680 Treatments of Internal Radiation With Resin 90Y-Microspheres for Unresectable Hepatic Tumors
  Andrew S. Kennedy, Patrick McNeillie, William A. Dezarn, Charles W. Nutting, Bruno Sangro, Dan Wertman, Michael Garafalo, David M. Liu, Douglas Coldwell, Michael Savin...> ;International Journal of Radiation Oncology, Biology, Physics. 2009 Aug 1
• 396 citations
  Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research...
  Stephen E. Jones, Frankie A. Holmes, Joyce O'Shaughnessy, Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John Pippen, James H. Bordelon, Robert Kirby, John...> ;Journal of Clinical Oncology. 2009 Mar 10
• 22 citations
  Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
  Mark A. Socinski, Robert N. Raju, Marcus A. Neubauer, David Smith, Donald A. Richards, Michael Savin, Robert L. Ruxer, Craig H. Reynolds, Feng Zhan, Jane Bromund, Ruqi...> ;Journal of Thoracic Oncology. 2008 Nov 1
• 126 citations
  Phase II Study of Weekly Albumin-Bound Paclitaxel for Patients with Metastatic Breast Cancer Heavily Pretreated with Taxanes
  Joanne L. Blum, Michael Savin, Gerald Edelman, J. Pippen, Nicholas J. Robert, Brian V. Geister, Robert Kirby, Alicia Clawson, Joyce A. O'Shaughnessy> ;Clinical Breast Cancer. 2007 Dec 1
• 381 citations
  Phase III Trial Comparing Doxorubicin Plus Cyclophosphamide With Docetaxel Plus Cyclophosphamide As Adjuvant Therapy for Operable Breast Cancer
  Stephen E. Jones, Michael Savin, Frankie A. Holmes, Joyce O'Shaughnessy, Joanne L. Blum, Svetislava J. Vukelja, Kristi J. McIntyre, John Pippen, James H. Bordelon, Rob...> ;Journal of Clinical Oncology. 2006 Dec 1
• 27 citations
  Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastatic liver carcinoma.
  Ching Yee Oliver Wong, Michael Savin, Kanchi M. Sherpa, Feng Qing, Janice Campbell, Vanessa L. Gates, Robert J. Lewandowski, Vincent Cheng, Joseph A. Thie, Darlene Fin...> ;Cancer Biotherapy & Radiopharmaceuticals. 2006 Sep 25
• A phase II study of a novel anti-tubulin, E7389, in patients with advanced non-small cell lung cancer (NSCLC).
  Das A, Spira A, Iannotti N, Savin M, Zang E, Datta K, Shapiro G, Patturajan M, Silberman S> ;J. Clin. Oncol.. 2006-06-20
• Join now to see all

Journal Articles

• Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker...  
  Yardley DA, Kaufman PA, Huang W, Krekow L, Savin MA, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Adams JW, Lie Y, Paquet AC, Sperinde J,..., Breast Cancer Research, 1/1/2015
• A Phase II Study of Eribulin Mesylate (E7389) in Patients With Advanced, Previously-Treated Non-Small Cell Lung Cancer  
  Spira AI, Iannotti NO, Savin MA, Neubauer M, Gabrail NY, Yanagihara RH, Zang EA, Cole PE, Shuster D, Das A, Clinical Lung Cancer, 1/1/2012
• Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7- Year Follow-Up of US Oncology Researc...  
  Jones S, Holmes FA, O’Shaughnessy J, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Richards DA, Mennel RG, Boehm KA, Meyer ..., Journal of Clinical Oncology, 1/1/2009
• Pemetrexed in relapsed small cell lung cancer and the impact of shortened vitamin supplementation lead-in time: Results of a phase II trial  
  Socinski M, Raju RN, Neubauer M, Smith DA, Richards DA, Savin MA, Ruxer RL, Reynolds CH, Zhan F, Bromund JL, Chen R, Obasaju C, Journal of Thoracic Oncology, 1/1/2008
• Phase II study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes  
  Blum JL, Savin MA, Edelman G, Pippen JE, Robert NJ, Geister BV, Kirby RL, Clawson A, and O’Shaughnessy JA, Clinical Breast Cancer, 1/1/2007
• Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer  
  Jones SE, Savin MA, Holmes FA, O’Shaughnessy JA, Blum JL, Vukelja SJ, McIntyre KJ, Pippen JE, Bordelon JH, Kirby RL, Sandbach J, Hyman WJ, Khandelwal P, Negron..., Journal of Clinical Oncology, 1/1/2006
• Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy  
  O'Shaughnessy JA, Vukelja SJ, Holmes FA, Savin M, Jones M, Royall D, George M, Von Hoff D, Clinical Breast Cancer, 1/1/2005
• Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients...  
  Holmes FA, O’Shaughnessy JA, Vukelja S, Jones SE, Shogan J, Savin M, Glaspy J, Moore M, Meza L, Wiznitzer I, Neumann TA, Hill LR, Liang BC, Journal of Clinical Oncology, 1/1/2002
• Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy- induced neutropenia: a multicenter dose-finding...  
  Holmes FA, Jones SE, O’Shaughnessy J, Vukelja S, George T, Savin M, Richards D, Glaspy J, Meza L, Cohen G, Dhami M, Budman DR, Hackett J, Brassard M, Yang BB, Liang BC, Annals of Oncology, 1/1/2002
• Adjuvant chemotherapy with doxorubicin and cyclophosphamide in women with rapidly proliferating node- negative breast cancer  
  Jones SE, Clark G, Koleszar S, Ethington G, Mennel R, Paulson S, Brooks B, Kerr R, Denham C, Savin M, Blum J, Kirby R, Stone M, Pippen J, George T, Orr D, Knox S, Gran..., Clinical Breast Cancer, 1/1/2002
• Low proliferative rate of invasive node-negative breast cancer predicts for a favorable outcome: a prospective evaluation of 669 patients  
  Jones S, Clark G, Koleszar S, Ethington G, Mennel R, Paulson S, Brooks B, Kerr R, Denham C, Savin M, White C, Blum J, Kirby R, Stone M, Pippen J, Kitchens L, George T..., Clinical Breast Cancer, 1/1/2001
• Adenovirus- Mediated p53 Gene Transfer in Advanced Non-Small-Cell Lung Cancer  
  Swisher SG, Roth JA, Nemunaitis J, Lawrence DD Kemp BL, Carrasco CL, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mac..., Journal of the National Cancer Institute, 1/1/1999
• A pilot study of intra-arterial chemotherapy with cisplatin in locally advanced head and neck cancers  
  Cheung DK, Regan J, Savin M, Gibberman V, and Woessner W, Cancer, 1/1/1988
• Growth suppression of human leukemic cells in vitro by L-ascorbic acid  
  Park CH, Amare M, Savin MA, and Hoogstraten B, Cancer Research, 1/1/1980
• Mucosal iron transport by rat intestine  
  Savin MA, and Cook JD, Blood, 1/1/1980
• Iron transport by isolated rat intestinal mucosal cells  
  Savin MA, and Cook JD, Gastroenterology, 1/1/1978
• Improved growth of in vitro colonies in human acute leukemia using the feeding culture method  
  Park CH, Savin MA, Hoogstraten B, Amare M, and Hathaway P, Cancer Research, 1/1/1977
• New tumor cell culture used to test drug effects  
  Park CH, Savin MA, Amare M, and Hoogstraten B, Communicator, 1/1/1977
• A practical approach to the treatment of iron deficiency  
  Savin MA, Rational Drug Therapy, 1/1/1977
• Regulation of homocysteine biosynthesis in Salmonella typhimurium  
  Savin MA, Flavin M, and Slaughter C, Journal of Bacteriology, 1/1/1972
• Cystathionine synthesis in yeast: An alternative pathway for homocysteine biosynthesis  
  Savin MA, and Flavin M, Journal of Bacteriology, 1/1/1972
• synchronization of converging metabolic pathways: Activation of the cystathionine gamma-synthase of Neurosporacrassa by methyl tetrahydrofolate  
  Selhub J, Savin MA, Sakami W, and Flavin M, Proceedings of the National Academy of Sciences, 1/1/1971
• Studies in glycogen storage disease IV Leukocyte Phosphorylase in a family with type VI GSD  
  Schwartz D, Savin MA, Drash A, and Fields J, Metabolism, 1/1/1970
• Tissue Culture and Experimental Embryology: The relationship between a science and a technique (Senior Honors Thesis)  
  Savin MA, 1/1/1965
• Join now to see all

Books/Book Chapters

• AMA Drug Evaluations 
  Chapter: Nutritional anemias 
  Savin MAEdition 7th,1991
• Conn’s Current Therapy 1982 
  Chapter: Anemia due to iron deficiency 
  Savin MAEditors: HF Conn.W.B. Saunders Co., Philadelphia, PA1982
• Harrison’s Principles Of Internal Medicine-Patient Management Problems: Pre-Test, Self-Assessment And Review 
  Chapter: “Problem Number 14” (Hemolytic Anemia, Hemoglobinopathy) 
  Savin MA, and Levere RDEditors: AJ Bollet.McGraw Hill, New York, NY1981

Abstracts/Posters

• Scalp Cooling Alopecia Prevention Trial (SCALP) for Patients with Early Stage Breast Cancer
  Nangia JR, Wang, T Rude, M Osborne, C Papish, M Abraham, J, Holmes F, Savin M, Paxman R, Hilsenbeck SG, Osborne K, Rimawi MF, ASCO 2016 Annual Meeting, 1/1/2016
• Abstract OT3-02-08: Scalp cooling alopecia prevention trial (SCALP) for patients with early stage breast cancer
  Nangia JR, Wang T, Rude M, Osborne C, Papish M, Abraham J, Holmes F, Savin M, Paxman R, Hilsenbeck SG, Osborne K, Rimawi MF, Ongoing Trials-Chemotherapy, San Antonio Breast Cancer Symposium, 1/1/2015
• CD30 expression in nonlymphomatous malignancies
  Sharman, J.P., Goldschmidt, J.H., Burke, J.M., Hellerstedt, B.A., McIntyre, K., Yasenchak, C.A., Boyd, T.E., Ruxer, R.L., Patel- Donnelly, D., Braiteh, F.S., Fo..., Annual meeting, American Society of Clinical Oncology, 1/1/2012
• Quantitative measurement of HER2 expression in breast cancers: comparison with “real world” testing in a multi-center Collaborative Biomarker Study (CBS) and correlati...
  Yardley DA, Kaufman PA, Adams JW, Krekow L, Savin, M, Lawler WE, Zrada S, Starr A, Einhorn H, Schwartzberg LS, Huang W, Weidler J, Lie Y, Paquet A, Haddad M,..., 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium, 1/1/2012
• Extended follow-up and analysis by age of the US Oncology Adjuvant trial 973%: docetaxel/cyclophosphamide is associated with an overall survival benefit compared to do...
  Jones S, Holmes F, O’Shaughnessy J, Blum J, Vukelaj S, McIntyre K, Pippen J, Bordelon J, Kirby R, Sandbach J, Hyman W, Khandelwal P, Negron A, Richards D, Mennel R, Bo..., 30th Annual San Antonio Breast Cancer Symposium, 1/13/2007
• Phase II study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced non-small- cell lung cancer (NSCLC)
  Spira A, Iannotti N, Savin M, Neubauer M, Gabrail N, Yanagihara R, Datta K, Zang E, Das A, Proceedings of the American Society of Clinical Oncology, 1/1/2007
• A phase II study of a novel anti-tubulin, E7389, in patients with advanced non-small cell lung cancer (NSCLC)
  Spira A, Iannotti N, Savin M, Das A, Zang E, Datta K, Shapiro G, Patturajan M, Silberman S, Proceedings of the American Society of Clinical Oncology, 1/1/2006
• Final analysis: TC (docetaxel/cyclophosphamide, 4 cycles) has a superior disease-free survival compared to standard AC (doxorubicin/cyclophosphamide) in 1016 women wit...
  Jones SE, Savin MA, Holmes FA, O'Shaughnessy JA, Blum JL, Vukelja SJ, George TK, McIntyre KJ, Pippen JE, Sandbach J, Kirby RL, Bordelon JH, Hyman WJ, Negron AG, Khande..., 28th Annual San Antonio Breast Cancer Symposium, 1/1/2005
• Long term disease control in taxane-refractory metastatic breast cancer treat with nab paclitaxel
  Blum JL, Savin MA, Pippen JE, Robert N, Sandbach J, Carrasco S, O’Shaughnessy JA, Breast Cancer I Session, 1/1/2004
• Weekly nanoparticle albumin paclitaxel (Abraxane) results in long-term disease control in patients with taxane- refractory metastatic breast cancer
  O’Shaughnessy JA, Blum JL, Sandbach JF, Savin M, Fenske E, Hawkins MJ, 27th Annual San Antonio Breast Cancer Symposium, 1/1/2004
• Three year results of a prospective randomized trial of adjuvant chemotherapy for patients (pts) with stage I-III operable, invasive breast cancer comp...
  Jones SE, Savin MA, Asmar L, Holmes FA, O’Shaughnessy JA, Blum JL, Vukelja SJ, George TK, McIntyre KJ, Pippen JE, Proceedings of the American Society of Clinical Oncology, 1/1/2003
• Effects of epoetin alfa (Procrit) on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant or neoadjuvant ch...
  O’Shaughnessy J, Vukelja S, Savin M, Holmes FA, Jones M, Royall D, George M, Von Hoff D, Proceedings of the American Society of Clinical Oncology, 1/1/2002
• Impact of epoetin alfa on cognitive function, asthenia, and quality of life in women with breast cancer receiving adjuvant or neoadjuvant chemotherapy: analysis of 6-m...
  O'Shaughnessy J, Vukelja S, Savin M, Holmes FA, Jones M, Royall D, George M, von Hoff D, 25th Annual San Antonio Breast Cancer Symposium, 1/1/2002
• A single dose of pegylated Filgrastim (SD/01) is as effective as daily Filgrastim for hematologic support of chemotherapy in breast cancer patients: Results of a r...
  Holmes FA, O’Shaughnessy J, Vukelja S, Shogan J, Savin M, Glaspy J, Moore M, Meza L, Wiznitzer I, Neumann TA, Hill LR, and Liang B, Proceedings of American Society of Clinical Oncology, 1/1/2001
• Preliminary results of a prospective randomized trial of adjuvant chemotherapy for patients (pts) with stage I-III operable, invasive breast cancer com...
  Jones SE, Savin M, Holmes FA, O’Shaughnessy JA, Blum JL, Vukelja SJ, George TK, McIntyre KJ, Pippen JE, Kirby RL, Bordelon JH, Sandbach JF, Hyman WJ, Schottstaedt MW, ..., Proceedings of the American Society of Clinical Oncology, 1/1/2001
• Adjuvant chemotherapy prior to ASCT for breast cancer: Less is more?
  Rosenfeld CS, Kerr R, Brooks BD, White CS, and Savin MA, Proceedings of the American Society of Clinical Oncology, 1/1/2000
• Older adolescents vary greatly from children in their route of referral to the Pediatric Oncologist and national trials
  Goldman S, Stafford C, Weinthal J, Kerr R, White C, Savin M, Brooks B, Rosenfeld C, and Lenarsky C, Proceedings of the American Society of Clinical Oncology, 1/1/2000
• Low proliferative rate of invasive node negative breast cancer predicts for a favorable outcome without adjuvant chemotherapy
  Jones S, Clark G, Koleszar S, Ethington G, Mennel R, Paulson S, Brooks B, Kerr R, Denham C, Savin M, White C, Blum J, Kirby R, Stone M, Pippen J, Kitchens L, George T,..., Proceedings of the American Society of Clinical Oncology, 1/1/1999
• A randomized, double-blinded trial of single-dose sustained duration Filgrastim (SD/01) versus Filgrastim (G) for hematologic support of patients treated with Docetaxe...
  Holmes FA, Neumann TA, Vukelja S, George T, Khandelwal P, Savin M, Kirby R, Hyman W, McIntyre K, Melnyk A, Jr., Huslig R, Budman DR, O’Shaughnessy JA, Jones SE, Hil..., Proceedings of the American Society of Clinical Oncology, 1/1/1999
• Prospective randomized trial of adjuvant chemotherapy comparing 4 courses of Adriamycin/Cyclophosphamide (AC) to 4 courses of Taxotere/Cyclophosphamide (TC) in patient...
  Savin MA and Jones SE, Taxotere Investigator’s Meeting, West Palm Beach, FL, 1/1/1999
• Phase II evaluation of carboplatinum and VP-16 for patients with metastatic breast cancer and only one prior chemotherapy regimen
  Barker L, Jones S, Savin M, Mennel R, Proceedings of the American Society of Clinical Oncology, 1/1/1992
• Intra-arterial chemotherapy in advanced oropharyngeal carcinoma
  Cheung DK, Regan J, Savin M, Woessner W. and Gibberman V, Society of Head and Neck Surgeons Annual Meeting, Colorado Springs, 1/1/1986
• Role of duodenal mucosal transferrin and ferritin in the regulation of iron absorption in rats with acute and chronic blood loss and hemolysis
  Savin MA, Southern Section Meeting, American Federation for Clinical Research, New Orleans, 1/1/1985
• Intra-arterial cisplatinum (DDP) and intra-venous Methotrexate (MTX) as preoperative therapy in advanced stage head and neck cancer
  Regan J, Savin M, and Cheung D, Proceedings of the American Society of Clinical Oncology, 1/1/1985
• Intra-arterial cisplatinum (DDP) and intra-venous Methotrexate (MTX) as preoperative therapy in advanced stage head and neck cancer
  Regan J, Savin M, and Cheung D, American Cancer Society, Virginia Division, Cancer Research Meeting, 1/1/1985
• Join now to see all